Jupiter Endovascular, Inc. announced that the full results of the SPIRARE II pivotal trial, evaluating the company’s Vert ...
Srinivas Attanti, MD, FACC Cardiologist and Interventional Cardiologist Citrus Cardiology Consultants, PLLC Florida ...
Real-world evidence comparing TCAR with TFCAS and CEA across surgical risk and symptom status and the role of the ENROUTE™ ...
A summary of four recent studies evaluating locoregional therapies for hepatocellular carcinoma and percutaneous ablation for ...
Reflections on CREST-2 and the evolving opinions around modern carotid revascularization.
Penumbra, Inc. announced that the FDA has granted clearance for the treatment of deep vein thrombosis (DVT) to the company&rsqu ...
At VIVA 2026, the Vascular InterVentional Advances conference, William A. Gray, MD, presented findings from a subgroup analysis ...
An interim analysis of the XTRACT registry included 102 patients with CLTI treated with BD’s Rotarex system at nine investigational sites. Technical success was achieved in 89.2% of patients, with ...
The ELEGANCE registry, which focuses on historically underrepresented populations to generate real-world evidence, evaluated en ...
One-year results from the prospective, multicenter, single-arm PROMISE III trial evaluated transcatheter arterialization of the ...
Six-month results from Esprit BTK PAS were reported in patients with chronic limb-threatening ischemia (CLTI) treated with the ...
A post hoc analysis of the randomized HI-PEITHO study examined potential predictors of major bleeding in patients with acute in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results